| 摘要 |
<p>The present invention relates to the crystalline base of the well known antidepressant drug citalopram, 1-Ä3 -(dimethylamino)propylÜ-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran -carbonitrile, formulations of said base, a process for the preparation of purified salts of citalopram, such as the hydrobromide, using the base, the salts obtained by said process and formulations containing such salts.</p> |
